Forbes December 27, 2022
Rita Numerof

The U.S. spends a lot of money on healthcare; a staggering $4.3 trillion overall and almost $13,000 per individual, which is significantly more than what most other major countries in the developed world spend per capita. And, as I recently opined in this column, we are also getting sicker as a nation – nearly half of the U.S. population now lives with at least one chronic condition, such as heart disease and diabetes, which are the two leading causes of death in our country. We can largely thank an unworkable fee-for-service (FFS) model, which prioritizes profits over patient outcomes, for the crisis we are facing today. This broken system has and continues to drive our nation’s failing healthcare delivery system...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: CMS, Govt Agencies, Healthcare System, HHS, Insurance, Medicare, Patient / Consumer, Payment Models, Population Health Mgmt, Pricing / Spending, Provider, Value Based
Medicare’s Selection Of 15 More Drugs For Price Negotiation Puts Spotlight Back On IRA
MedPAC Members Vote to Recommend Pay Hikes for Physicians and Hospitals
Medicare will negotiate Novo’s GLP-1 drug price. Here’s what that means for Ozempic, Wegovy.
HHS: Ozempic, Wegovy will be part of Medicare Part D drug price negotiations this year
CMS says record 24.2 million enrolled in Marketplace coverage for 2025

Share This Article